T3D Therapeutics, Inc.

T3D Therapeutics’ mission is to develop its lead drug product candidate, T3D-959, as a potential ‘First-in-Class’ and ‘Best-in-Class’ disease-modifying, breakthrough medicine for the treatment of Alzheimer’s disease with the potential to slow, stop or reverse the course of the disease. The Company is also seeking to maximize the therapeutic utility of T3D-959 and has initiated pre-clinical studies in Huntington’s Disease models.

网站

http://www.t3dtherapeutics.com

T3D Therapeutics, Inc.的外部链接

所属行业

制药业

规模

2-10 人

总部

Durham，North Carolina

类型

私人持股